Neuronetics (STIM) EBT Growth (3y) (2020 - 2026)
Analysis
Neuronetics (STIM) EBT Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn | -2.34% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 28.31% |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 13.94% |
| 4 | Stryker | 104.88 Bn | 101.41 Bn | 4.50 Bn | 20.27% |
| 5 | Boston Scientific | 66.35 Bn | 65.81 Bn | 3.85 Bn | 35.51% |
| 6 | Edwards Lifesciences | 49.66 Bn | 45.41 Bn | 1.35 Bn | 23.63% |
| 7 | Alcon | 33.90 Bn | 32.44 Bn | 1.68 Bn | -30.37% |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 25.85% |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn | 17.92% |
| 10 | Neuronetics | 227.07 Mn | 207.63 Mn | 21.22 Mn | 24.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.70% |
| Mar 31, 2026 | -0.30% |
| Dec 31, 2025 | 6.27% |
| Sep 30, 2025 | -3.81% |
| Jun 30, 2025 | 2.43% |
| Mar 31, 2025 | -5.19% |
| Dec 31, 2024 | -18.39% |
| Sep 30, 2024 | -4.96% |
| Jun 30, 2024 | -11.61% |
| Mar 31, 2024 | -3.23% |
| Dec 31, 2023 | -19.54% |
| Sep 30, 2023 | -43.17% |
| Jun 30, 2023 | -2.68% |
| Mar 31, 2023 | 2.09% |
| Dec 31, 2022 | -4.45% |
| Sep 30, 2022 | -5.47% |
| Jun 30, 2022 | -12.72% |
| Mar 31, 2022 | -11.69% |
| Dec 31, 2021 | -6.50% |
| Sep 30, 2021 | -15.83% |